Chemical Name: 7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole
Biological ActivityPotent and selective inhibitor of DYRK1A (IC50 values are 80, 800 and 900 nM for DYRK1A, DYRK3 and DYRK2 respectively). Inhibits DYRK1A-mediated tau phosphorylation and regulates PPARγ expression. Also induces pancreatic beta cell proliferation. Exhibits antidiabetic activity. Orally bioavailable.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?
Smith et al.
ACS Chem.Neurosci., 2012;3:857
The selectivity of protein kinase inhibitors: a further update.
Bain et al.
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication.
Wang et al.
The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression.
Waki et al.
Cell Metab., 2007;5:357
Citation for Harmine
The citations listed below are publications that use Tocris products. Selected citations for Harmine include:
1 Citation: Showing 1 - 1
Different developmental histories of beta-cells generate functional and proliferative heterogeneity during islet growth.
Authors: Singh Et al.
Nat Commun 2017;8:664
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Harmine
There are currently no reviews for this product. Be the first to review Harmine and earn rewards!
Have you used Harmine?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image